Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
INIndivior Pharmaceuticals Inc logo

Indivior Pharmaceuticals Inc (INDV)

NASDAQ Global Select · Currency in USD
$34.47 ▼ -0.86 (-2.43%)
At close: Oct 23, 4:00 PM ET. Market closed.
$34.47 ▲ +0.00 (+0.00%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$35.33
Open
$35.09
Day's Range
$34.10 – $35.22
52 Week Range
$24.28 – $42.81
Volume
1,484,012
Avg. Volume
2,195,339
Market Cap
$4.30B
Beta (5Y Monthly)
1.11
PE Ratio (TTM)
12.14
EPS (TTM)
$2.83
Earnings Date
Oct 29, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
Nov 3, 2026
1y Target Est
$48.00

Profile: Indivior Pharmaceuticals Inc

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full-time employees
833
CEO
Joseph J. Ciaffoni

Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market.

Earnings

Next report: Thu, Oct 29, 2026
EPS estimate $1.06 · Revenue est. $329.35M
DateEst.Actual
Aug 3, 2026$0.87$1.15Beat
Apr 30, 2026$0.64$0.96Beat
Feb 26, 2026$0.65$0.82Beat
Oct 30, 2025$0.38$0.72Beat
Jul 31, 2025$0.26$0.51Beat
Apr 24, 2025$0.22$0.41Beat

Analyst view

Consensus price target
$48.00 ▲ +39.3%
Range $43.00 – $53.00
Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Similar stocks

Get free alerts on INDV and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.